A bill that includes a provision co-authored by U.S. Sen. Susan Collins to lower drug prices awaits President Donald Trump’s signature. The provision, part of the Food and Drug Administration’s Reauthorization Act, seeks to keep prescription drug prices down by speeding up timelines and inspection procedures for the FDA’s review of applications for generic drug […]